Clinical Trial Update: Galactomannan Antigen in Bronchoalveolar Lavage in the Diagnosis of Invasive Aspergillosis in Neutropenic Patients

View source ↗

Summary

A completed clinical trial evaluating galactomannan antigen in bronchoalveolar lavage for diagnosing invasive aspergillosis in neutropenic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Invasive Aspergillosis | Status: COMPLETED